Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22244160 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Chemoembolization and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed With Surgery
Condition: Liver Cancer
Intervention: Biological: bevacizumab

Indicates status has not been verified in more than two years